The risk of stroke after thrombolytic therapy.

The risk of stroke after thrombolytic therapy.

Bibliografski detalji
Glavni autori:	Collins, R, Sleight, P, Maggioni, A
Format:	Journal article
Jezik:	English
Izdano:	1992

Slični predmeti

Wider inclusion criteria needed for thrombolytic therapy.
od: Peto, R, i dr.
Izdano: (1989)

Thrombolytic Therapy in Acute Stroke
od: Yen-Wei Hsu, i dr.
Izdano: (2008-09-01)

Thrombolytic therapy for ischemic stroke
od: Natalia Vyacheslavovna Pizova
Izdano: (2013-11-01)

Risks and benefits of early antithrombotic therapy after thrombolytic treatment in patients with acute stroke.
od: Sergio Amaro, i dr.
Izdano: (2013-01-01)

Carotid Endarterectomy in the Acute Period of Ischemic Stroke After Thrombolytic Therapy
od: D. А. Nekrasov, i dr.
Izdano: (2024-10-01)

Modeling the outcomes of thrombolytic therapy in ischemic stroke
od: Yuliya D. Minina, i dr.
Izdano: (2022-12-01)

Endovascular and Thrombolytic Therapy and the Functional Status of Patients after Ischemic Stroke
od: Renata Jabłońska, i dr.
Izdano: (2019-06-01)

Short-term outcome in ischemic stroke patients after thrombolytic therapy
od: Wafaa S. Mohamed, i dr.
Izdano: (2021-01-01)

Intravenous Thrombolytic Therapy in Acute Ischemic Stroke
od: Semai Bek, i dr.
Izdano: (2009-12-01)

Thrombolytic therapy for acute stroke: The hidden dimension.
od: Ossama eMansour, i dr.
Izdano: (2010-09-01)

Quality of life of elderly ischaemic stroke patients one year after thrombolytic therapy. A comparison between patients with and without thrombolytic therapy
od: de Weerd Leonie, i dr.
Izdano: (2012-07-01)

The effect of modifiable stroke risk factors on systemic thrombolytic therapy in patients with acute stroke
od: Sergey V. Kotov, i dr.
Izdano: (2021-03-01)

Thrombolytic therapy in patients with ischemic stroke in the vertebrobasilar system
od: K V Anisimov, i dr.
Izdano: (2012-09-01)

Systemic Thrombolytic Therapy for Ischemic Stroke in the Course of Anticoagulants
od: L. Kh.-B. Akhmatkhanova, i dr.
Izdano: (2021-11-01)

Difficult questions of intravenous thrombolytic therapy in ischemic stroke
od: Aleksey A. Kulesh
Izdano: (2021-11-01)

Prediction of ischemic stroke outcome during thrombolytic therapy
od: Yu. D. Minina, i dr.
Izdano: (2020-12-01)

Informed consent for thrombolytic therapy in acute ischemic stroke.
od: Sivakumar, C, i dr.
Izdano: (2005)

Thrombolytic therapy in patients with acute ischemic or hemorrhagic stroke
od: O. A. Tsimeyko, i dr.
Izdano: (2007-03-01)

Assessment of the Functional Status of Patients after Ischemic Stroke Treated with Thrombolytic Therapy
od: Danuta Sternal, i dr.
Izdano: (2024-06-01)

Outcomes of Intravenous Thrombolytic Therapy in Acute Ischemic Stroke
od: Aysu Yetiş, i dr.
Izdano: (2024-01-01)

Intravenous Thrombolytic Therapy in Acute Stroke: Problems and Solutions
od: Mehmet Akif Topçuoğlu, i dr.
Izdano: (2017-12-01)

Opportunities in multimodal neuroimaging for optimizing thrombolytic therapy for ischemic stroke
od: M. M. Odinak, i dr.
Izdano: (2016-03-01)

Acute Ischemic Stroke and Heart Failure: Stroke Risk Factors Associated with Exclusion from Thrombolytic Therapy
od: Carolyn Breauna Sanders BSc, i dr.
Izdano: (2022-10-01)

The results of systemic thrombolytic therapy for acute ischemic stroke in women and men depending on the stroke risk factors
od: Sergey V. Kotov, i dr.
Izdano: (2023-02-01)

Intravenous Thrombolytic Therapy in Acute Ischemic Stroke: The Experience of Kütahya
od: Mustafa Çetiner, i dr.
Izdano: (2017-12-01)

Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients
od: Nicolas Poupore, i dr.
Izdano: (2020-05-01)

Repeated Thrombolytic Therapy in Patients with Recurrent Acute Ischemic Stroke
od: Han Soo Yoo, i dr.
Izdano: (2013-09-01)

Effectiveness of Thrombolytic Therapy in Acute Embolic Stroke due to Infective Endocarditis
od: Siva P. Sontineni, i dr.
Izdano: (2010-01-01)

Disruptions of Circadian Rhythms and Thrombolytic Therapy During Ischemic Stroke Intervention
od: Jennifer A. Liu, i dr.
Izdano: (2021-06-01)

Renal Dysfunction and In‐Hospital Outcomes in Patients With Acute Ischemic Stroke After Intravenous Thrombolytic Therapy
od: Zhen‐Zhen Rao, i dr.
Izdano: (2019-10-01)

Effects of cholesterol-lowering therapy and antioxidant vitamin supplementation on the risk of stroke
od: Collins, R, i dr.
Izdano: (2002)

Thrombolytic Administration for Acute Ischemic Stroke
od: Abraham Akbar, i dr.
Izdano: (2022-03-01)

Building a "brain attack" team to administer thrombolytic therapy for acute ischemic stroke.
od: Hill, MD, i dr.
Izdano: (2000)

EVALUATION OF EARLY ISCHEMIC CHANGES IN STROKE PATIENTS TREATED WITH THROMBOLYTIC THERAPY
od: Kolevski Goran, i dr.
Izdano: (2016-07-01)

Thrombolytic therapy based on lyophilized platelet-derived nanocarriers for ischemic stroke
od: Martina Migliavacca, i dr.
Izdano: (2024-01-01)

Intravenous Thrombolytic Therapy in Acute Stroke: Frequent Systemic Problems and Solutions
od: Mehmet Akif Topçuoğlu, i dr.
Izdano: (2018-03-01)

Thrombolytic Therapy for Stroke in Turkey: Meta-analysis of Published Case Series
od: Mustafa Çetiner, i dr.
Izdano: (2020-06-01)

Effects of Nursing Quality Improvement on Thrombolytic Therapy for Acute Ischemic Stroke
od: Zhuo Liu, i dr.
Izdano: (2018-11-01)

The Presence of Visual Neglect after Thrombolytic Treatment in Patients with Right Hemisphere Stroke
od: J. E. Kettunen, i dr.
Izdano: (2012-01-01)

Therapeutic Effect of Thrombolytic Therapy on Motor Function Loss After Ischaemic Stroke: A Case Study
od: Esra Karakoç, i dr.
Izdano: (2024-06-01)